Approval-standardized postmarketing safety reporting phenotypes of talquetamab versus BCMA-directed bispecific antibodies in multiple myeloma

Leukemia Research · Elsevier

Аннотация

Publication date: December 2026 Source: Leukemia Research, Volume 171 Author(s): He Zhu, Wenxi He

Читать у издателя →

Похожие статьи